volume increased by 483 thousand shares traded.Apparently, there must be some reason that activated the stock to start the climb.
The most reasonable explanation for the gain appeared to be the latest news about Pro-Pharmaceuticals. Yesterday, the company announced it was chosen to receive $489 thousand in federal grants for its Galectin-Targeting Cancer and Liver Fibrosis compounds. Mr. James Czirr, Executive Chairman and co-founder of Pro-Pharmaceuticals, claimed he was optimistic about accelerating the company’s pre-clinical trials and its new drug application.
Though the trials are not yet released, it seems that the news encouraged investors and PRWP share price rose up immediately.[BANNER]
Pro-Pharmaceuticals, Inc. engages in the field of Galectin therapeutics and in the discovery, development and commercialization of therapeutics that target Galectin receptors for advanced treatment of cancer and fibrosis.
Previously, the company published some positive announcements and hit another huge gain, however, it didn’t last for long.
